Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 07:00 ET | Source: Exicure, Inc.

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the...
February 05, 2026 06:18 ET | Source: BCC Research LLC

Global Demand for Carbon Fiber Continues to Rise

Carbon Fiber Global Markets was valued at $4.9 billion in 2024 and is estimated to increase from $5.3 billion in 2025 to $8.2 billion by 2030.
February 05, 2026 04:45 ET | Source: Ontex

Ontex lanceert Sensitive-gamma om een betere huidgezondheid in incontinentiezorg te ondersteunen

Aalst, België – 5 februari 2026 – Ontex Group NV, een toonaangevende ontwikkelaar en producent van persoonlijke verzorgingsproducten, introduceert een nieuw incontinentie-gamma voor volwassenen dat...
February 05, 2026 04:45 ET | Source: Ontex

Ontex launches Sensitive range to support better skin health in incontinence care

Ontex introduces a new adult incontinence range developed to offer superior protection while being gentle on the skin.
February 05, 2026 03:00 ET | Source: Alvotech

Alvotech kynnir jákvæða niðurstöðu rannsóknar á lyfjahvörfum AVT80, fyrirhugaðrar hliðstæðu við líftæknilyfið Entyvio

Allir endapunktar rannsóknarinnar voru uppfylltir, en hún bar saman lyfjahvörf, öryggi, þolanleika og ónæmingarverkun AVT80 og Entyvio í heilbrigðum einstaklingum Alvotech (NASDAQ: ALVO, ALVO SDB)...
February 05, 2026 03:00 ET | Source: Alvotech

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints REYKJAVIK, ICELAND...
February 04, 2026 18:11 ET | Source: Novarad Corporation

Novarad to Attend 2026 Society of Interventional Oncology Annual Scientific Meeting in Savannah, Georgia

Savannah. GA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Novarad will attend the Society of Interventional Oncology (SIO) Annual Scientific Meeting, taking place this year in Savannah, Georgia at...
February 04, 2026 17:16 ET | Source: His Choice Health

His Choice Health Launches Unified Men’s Health Brand After 10,000+ Vasectomy Procedures

Raleigh, NC, Feb. 04, 2026 (GLOBE NEWSWIRE) -- His Choice Raleigh and His Choice Durham today announced their official unification under a new brand, His Choice Health, bringing together two...
February 04, 2026 16:47 ET | Source: Tempest Therapeutics

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

All-stock transaction brings Tempest a portfolio of next-generation CAR-T assets, including TPST-2003, a clinical-stage dual-targeting CD-19/BCMA CAR-T with strategic partner-funded BLA filing in...
February 04, 2026 16:21 ET | Source: Banner Health

Banner Health names new senior vice president of finance

PHOENIX, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Banner Health announced the new senior vice president of finance as Shelby Arveson, joining the organization Jan. 26. In this role, Arveson will direct...